ATE289999T1 - Cis-substituierte aminocyclopropanderivate - Google Patents
Cis-substituierte aminocyclopropanderivateInfo
- Publication number
- ATE289999T1 ATE289999T1 AT97930766T AT97930766T ATE289999T1 AT E289999 T1 ATE289999 T1 AT E289999T1 AT 97930766 T AT97930766 T AT 97930766T AT 97930766 T AT97930766 T AT 97930766T AT E289999 T1 ATE289999 T1 AT E289999T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- hydrogen atom
- alkyl
- alkoxyl
- alkenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18293996 | 1996-07-12 | ||
PCT/JP1997/002411 WO1998002431A1 (en) | 1996-07-12 | 1997-07-11 | cis-SUBSTITUTED AMINOCYCLOPROPANE DERIVATIVES |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE289999T1 true ATE289999T1 (de) | 2005-03-15 |
Family
ID=16127021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97930766T ATE289999T1 (de) | 1996-07-12 | 1997-07-11 | Cis-substituierte aminocyclopropanderivate |
Country Status (12)
Country | Link |
---|---|
US (3) | US6391889B2 (de) |
EP (1) | EP0919553B1 (de) |
JP (1) | JP4094061B2 (de) |
KR (1) | KR100488284B1 (de) |
CN (1) | CN1113064C (de) |
AT (1) | ATE289999T1 (de) |
AU (1) | AU3459797A (de) |
DE (1) | DE69732635T2 (de) |
DK (1) | DK0919553T3 (de) |
ES (1) | ES2238723T3 (de) |
PT (1) | PT919553E (de) |
WO (1) | WO1998002431A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4694669B2 (ja) | 1999-03-17 | 2011-06-08 | 第一三共株式会社 | 医薬組成物 |
JP2005232000A (ja) * | 2000-03-10 | 2005-09-02 | Dainippon Pharmaceut Co Ltd | ピリドンカルボン酸誘導体又はその塩 |
US6608078B2 (en) | 2000-05-08 | 2003-08-19 | Wockhardt Limited | Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment |
US7098219B2 (en) | 2000-08-01 | 2006-08-29 | Wockhart Limited | Inhibitors of cellular efflux pumps of microbes |
DE60130359T2 (de) * | 2000-11-20 | 2008-06-26 | Daiichi Sankyo Co., Ltd. | Deshalogenverbindungen |
US6878713B2 (en) | 2001-04-25 | 2005-04-12 | Wockhardt Limited | Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
US6964966B2 (en) | 2001-04-25 | 2005-11-15 | Wockhardt Limited | Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
WO2003099815A1 (en) | 2002-05-28 | 2003-12-04 | Wockhardt Limited | Crystalline fluoroquinolone arginine salt form |
JP5255183B2 (ja) | 2003-09-04 | 2013-08-07 | ウォックハート リミテッド | ベンゾキノリジン−2−カルボン酸アルギニン塩四水和物 |
JP4691189B1 (ja) | 2009-11-25 | 2011-06-01 | 株式会社東芝 | 直接メタノール型燃料電池 |
CN105315188B (zh) * | 2014-06-03 | 2018-10-16 | 武汉药明康德新药开发有限公司 | 一种2-(1-(叔丁氧羰基)氮杂环丁基-3-)环丙基甲酸的制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE55898B1 (en) | 1982-09-09 | 1991-02-14 | Warner Lambert Co | Antibacterial agents |
IL79189A (en) | 1985-06-26 | 1990-07-12 | Daiichi Seiyaku Co | Quinoline and/or naphthyridine-4-oxo-3-carboxylic acid derivatives,process for their preparation and pharmaceutical compositions comprising them |
US4954507A (en) * | 1986-10-08 | 1990-09-04 | Bristol-Myers Company | 1-tertiary-alkyl-substituted naphthyridine carboxylic acid antibacterial agents |
US4920120A (en) | 1988-01-25 | 1990-04-24 | Warner-Lambert Company | Antibacterial agents |
US5173484A (en) * | 1988-02-05 | 1992-12-22 | Bayer Aktiengesellschaft | Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them |
US5580872A (en) * | 1990-05-02 | 1996-12-03 | Abbott Laboratories | Quinolizinone type compounds |
FR2676445B1 (fr) | 1991-05-16 | 1995-02-03 | Esteve Labor Dr | Derives de pyridone amino acide azetidinyl substitues, leur preparation et leur application en tant que medicaments. |
JPH07300472A (ja) * | 1992-12-28 | 1995-11-14 | Korea Res Inst Chem Technol | 新規キノロンカルボン酸誘導体およびその製造方法 |
TW420610B (en) | 1994-04-07 | 2001-02-01 | Pfizer | A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers |
JPH0848629A (ja) * | 1994-08-08 | 1996-02-20 | Dainippon Pharmaceut Co Ltd | ピリドンカルボン酸誘導体およびそれを有効成分とする抗ピロリ菌剤 |
JP3745433B2 (ja) | 1995-02-02 | 2006-02-15 | 第一製薬株式会社 | 複素環式化合物 |
JP3771620B2 (ja) | 1995-02-07 | 2006-04-26 | 第一製薬株式会社 | ヘテロ環式スピロ誘導体 |
-
1997
- 1997-07-11 JP JP50584098A patent/JP4094061B2/ja not_active Expired - Fee Related
- 1997-07-11 DK DK97930766T patent/DK0919553T3/da active
- 1997-07-11 EP EP97930766A patent/EP0919553B1/de not_active Expired - Lifetime
- 1997-07-11 ES ES97930766T patent/ES2238723T3/es not_active Expired - Lifetime
- 1997-07-11 CN CN97197630A patent/CN1113064C/zh not_active Expired - Fee Related
- 1997-07-11 PT PT97930766T patent/PT919553E/pt unknown
- 1997-07-11 US US09/214,433 patent/US6391889B2/en not_active Expired - Fee Related
- 1997-07-11 AT AT97930766T patent/ATE289999T1/de not_active IP Right Cessation
- 1997-07-11 KR KR10-1999-7000168A patent/KR100488284B1/ko not_active IP Right Cessation
- 1997-07-11 DE DE69732635T patent/DE69732635T2/de not_active Expired - Lifetime
- 1997-07-11 WO PCT/JP1997/002411 patent/WO1998002431A1/ja active IP Right Grant
- 1997-07-11 AU AU34597/97A patent/AU3459797A/en not_active Abandoned
-
2001
- 2001-07-19 US US09/907,909 patent/US6462040B1/en not_active Expired - Fee Related
-
2002
- 2002-03-28 US US10/107,339 patent/US6949662B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2238723T3 (es) | 2005-09-01 |
EP0919553B1 (de) | 2005-03-02 |
PT919553E (pt) | 2005-05-31 |
US20020052502A1 (en) | 2002-05-02 |
KR100488284B1 (ko) | 2005-05-11 |
AU3459797A (en) | 1998-02-09 |
DK0919553T3 (da) | 2005-06-06 |
JP4094061B2 (ja) | 2008-06-04 |
CN1113064C (zh) | 2003-07-02 |
DE69732635D1 (de) | 2005-04-07 |
US20020002182A1 (en) | 2002-01-03 |
DE69732635T2 (de) | 2005-12-29 |
EP0919553A4 (de) | 2002-06-12 |
US6949662B2 (en) | 2005-09-27 |
US6462040B1 (en) | 2002-10-08 |
US6391889B2 (en) | 2002-05-21 |
US20020183523A1 (en) | 2002-12-05 |
EP0919553A1 (de) | 1999-06-02 |
KR20000023709A (ko) | 2000-04-25 |
WO1998002431A1 (en) | 1998-01-22 |
CN1228776A (zh) | 1999-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0211844B8 (pt) | composto de ácido fenóxi-acético ou um de seus sais farmaceuticamente aceitáveis, e, composição farmacêutica | |
CA2212007A1 (en) | Pyridonecarboxylic acid derivatives substitued by a bicyclic amino group | |
TW231258B (de) | ||
DK0919553T3 (da) | cis-substituerede aminocyclopropanderivater | |
MY136916A (en) | Antibacterial dehaloganated quinolone compounds | |
MY125894A (en) | Cycloalkyl-substituted aminomethylpyrrolidine derivatives | |
DE69814800D1 (de) | Epoxysuccinamid-derivate oder ihre salze | |
MY132897A (en) | Cis- substituted fluoromethylpyrrolidine derivative | |
DE69930383D1 (de) | Naphthimidobenzamid-derivate | |
PT99983A (pt) | Processo para a preparacao de compostos cefalosporinicos uteis como agentes antibacterianos | |
ES2180975T3 (es) | Derivados de cicloalquilaminometilpirrolidina. | |
EP0407621A4 (en) | Benzothiazole derivatives | |
AU8003594A (en) | Quinolinecarboxylic acid derivative and salt thereof | |
TW350835B (en) | Process for preparing nitroaniline derivatives | |
ATE331720T1 (de) | Pyridobenzoxazinderivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0919553 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |